A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...

Careful analysis of the seemingly intractable problem of rising medical costs can typically be reduced to three things: 1) ...

A judge on Tuesday rejected a challenge from major pharmaceutical companies against Washington’s new law trying to reduce ...

Amid barbs over the shutdown and broader healthcare funding cuts, a Thursday committee hearing brought bipartisan agreement that more can be done to ensure the pricey drug subsidy program remains a ...

Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in ...

Established under the Public Health Service Act in 1992, the 340B drug pricing program has a critical goal: improve access to medicines for low-income patients at qualifying hospitals and clinics.

WASHINGTON: The U.S. Department of Health and Human Services building is shown in Washington, DC. (Photo by Mark Wilson/Getty Images) In 1992, Congress created the 340B Drug Pricing Program to provide ...

The 340B program was originally designed to assist hospitals that treat under- or uninsured patients in receiving discounted pharmaceutical drugs. Now, the federal subsidy program is getting a second ...

Illinois lawmakers passed two bills balancing hospital protections and audits for the federal 340B drug program.

Participation in the 340B Drug Pricing Program by general acute care hospitals and critical access hospitals has not been associated with increased provision of uncompensated care. Objectives: To ...